As of Jul 30
| -0.55 / -1.78%|
The 8 analysts offering 12-month price forecasts for Medicines Co have a median target of 34.50, with a high estimate of 42.00 and a low estimate of 28.00. The median estimate represents a +13.49% increase from the last price of 30.40.
The current consensus among 9 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.